Ligand validation:8VZF

FYN: S-{(9R,13S,15R)-17-[(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXY-3-(PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]-9,13,15-TRIHYDROXY-10,10-DIMETHYL-13,15-DIOXIDO-4,8-DIOXO-12,14,16-TRIOXA-3,7-DIAZA-13,15-DIPHOSPHAHEPTADEC-1-YL} THIOFORMATE

FYN is a Ligand Of Interest in 8VZF designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8VZF_FYN_C_601	88%	53%	0.077	0.953	0.8	1.03	1	2	7	0	100%	0.9782
8VZF_FYN_D_601	86%	51%	0.078	0.945	0.83	1.07	3	1	7	0	100%	0.9854
8VZF_FYN_B_601	85%	48%	0.08	0.944	0.81	1.19	3	3	5	0	100%	0.9849
8VZF_FYN_A_601	84%	52%	0.083	0.946	0.8	1.06	1	2	4	0	100%	0.9825
8VZC_FYN_A_602	94%	41%	0.069	0.966	0.81	1.48	1	6	2	0	100%	0.988
8VZD_FYN_A_602	70%	53%	0.096	0.915	0.79	1.03	3	2	2	0	98%	0.9697
7PT4_FYN_A_715	25%	55%	0.173	0.806	0.69	1.03	1	2	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.